Omalizumab improves forced expiratory volume in 1 second in patients with severe asthma

INTRODUCTION: Asthma is a multiphenotypic disease, and therapeutic managenment in patients with severe asthma is particulary difficult, with conventional treatment of severe asthma showing poor efficacy. AIM: To analyse forced expiratory volume in 1 s (FEV(1)) following the adminstration of omalizum...

Descripción completa

Detalles Bibliográficos
Autores principales: Pałgan, Krzysztof, Żbikowska-Götz, Magdalena, Lis, Kinga, Chrzaniecka, Elżbieta, Bartuzi, Zbigniew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232554/
https://www.ncbi.nlm.nih.gov/pubmed/30429708
http://dx.doi.org/10.5114/ada.2018.77241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232554/
https://www.ncbi.nlm.nih.gov/pubmed/30429708
http://dx.doi.org/10.5114/ada.2018.77241

Ejemplares similares